Skip to content

Complex slow waves radically reorganise human brain dynamics under 5-MeO-DMT

George Blackburne, Rosalind McAlpine, Marco S. Fabus, Alberto Liardi, Sunjeev K. Kamboj, Pedro A. M. Mediano, Jeremy I Skipper

bioRxiv (Cold Spring Harbor Laboratory) October 7, 2024 preprint DOI: 10.1101/2024.10.04.616717 (opens in new tab)

Read Full Text
Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort
Sample size 29
Population Healthy individuals
Intervention 5-MeO-DMT
Dose 12mg
Topics 5-MeO-DMT DMT
Keywords Dynamics music Brain waves Human brain Electroencephalography Acoustics
Citations 8
Key findings 5-MeO-DMT radically reorganizes low-frequency neural activity flows, making them incoherent, heterogeneous, viscous, fleeting, and nonrecurring, and causes broadband activity to become slower, more stable, and low-dimensional.

Abstract

Abstract 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychedelic drug known for its uniquely profound effects on subjective experience, reliably eradicating the perception of time, space, and the self. However, little is known about how this drug alters large-scale brain activity. We collected naturalistic electroencephalography (EEG) data of 29 healthy individuals before and after inhaling a high dose (12mg) of vaporised synthetic 5-MeO-DMT. We replicate work from rodents showing amplified low-frequency oscillations, but extend these findings with novel tools for characterising the organisation and dynamics of complex low-frequency spatiotemporal fields of neural activity. We find that 5-MeO-DMT radically reorganises low-frequency flows of neural activity, causing them to become incoherent, heterogeneous, viscous, fleeting, nonrecurring, and to cease their typical travelling forwards and backwards across the cortex compared to resting state. Further, we find a consequence of this reorganisation in broadband activity, which exhibits slower, more stable, low-dimensional behaviour, with increased energy barriers to rapid global shifts. These findings provide the first detailed empirical account of how 5-MeO-DMT sculpts human brain dynamics, revealing a novel set of cortical slow wave behaviours, with significant implications for extant neuroscientific models of serotonergic psychedelics.

Comparable studies

Other observational and cohort studies on 5-MeO-DMT, most cited first.

Study Year Design Participants
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms. Volunteers who inhaled vapor from dried toad secretion at several European locations 2019 Observational cohort n = 42
Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study Individuals at a psychospiritual retreat in Mexico 2018 Observational cohort n = 20
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings. Healthy and experienced participants 2021 Observational field study n = 35
A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers. Healthy volunteers 2021 Prospective dose-finding study n = 22
Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico. Trauma-exposed Special Operations Forces Veterans 2023 Prospective clinical program evaluation n = 86

Citations in the library

Cited by 6

and 1 more in the library

Cites 35

and 30 more in the library

Related reading

Explore topics

5-MeO-DMT DMT Serotonin